Goldman Sachs’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110M | Buy |
|
|||||
|
2025
Q1 | $86.8M | Sell |
|
|||||
|
2024
Q4 | $101M | Sell |
|
|||||
|
2024
Q3 | $203M | Sell |
|
|||||
|
2024
Q2 | $217M | Buy |
|
|||||
|
2024
Q1 | $221M | Buy |
|
|||||
|
2023
Q4 | $232M | Sell |
|
|||||
|
2023
Q3 | $118M | Sell |
|
|||||
|
2023
Q2 | $85.5M | Sell |
|
|||||
|
2023
Q1 | $94.7M | Buy |
|
|||||
|
2022
Q4 | $151M | Buy |
|
|||||
|
2022
Q3 | $117M | Buy |
|
|||||
|
2022
Q2 | $13.1M | Sell |
|
|||||
|
2022
Q1 | $38.5M | Buy |
|
|||||
|
2021
Q4 | $30.9M | Buy |
|
|||||
|
2021
Q3 | $37.9M | Buy |
|
|||||
|
2021
Q2 | $20.9M | Buy |
|
|||||
|
2021
Q1 | $14M | Buy |
|
|||||
|
2020
Q4 | $1.56M | Sell |
|
|||||
|
2020
Q3 | $1.22M | Buy |
|
|||||
|
2020
Q2 | $738K | Sell |
|
|||||
|
2020
Q1 | $790K | Sell |
|
|||||
|
2019
Q4 | $1.49M | Buy |
|
|||||
|
2019
Q3 | $1.12M | Sell |
|
|||||
|
2019
Q2 | $1.23M | Buy |
|
|||||
|
2019
Q1 | $1.29M | Buy |
|
|||||
|
2018
Q4 | $538K | Buy |
|
|||||
|
2018
Q3 | $305K | Buy |
|
|||||
|
2018
Q2 | $235K | Buy |
|